Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study

Melanoma is an aggressive malignancy with a poor prognosis. Current studies show that imatinib treatment is a promising approach in treating advanced melanoma patients harboring c-Kit mutations or amplifications. We retrospectively analyzed the clinical medical records of 78 patients with metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xiaoting, Mao, Lili, Chi, Zhihong, Sheng, Xinan, Cui, Chuanliang, Kong, Yan, Dai, Jie, Wang, Xuan, Li, Siming, Tang, Bixia, Lian, Bin, Yan, Xieqiao, Bai, Xue, Zhou, Li, Guo, Jun, Si, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848371/
https://www.ncbi.nlm.nih.gov/pubmed/30075827
http://dx.doi.org/10.3727/096504018X15331163433914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848371/
https://www.ncbi.nlm.nih.gov/pubmed/30075827
http://dx.doi.org/10.3727/096504018X15331163433914

Ejemplares similares